Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.

Saved in:
Bibliographic Details
Title: Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
Authors: Cukierman-Yaffe T; Endocrinology Institute, Sheba Medical Center, Ramat-Gan, and Epidemiology Department, Sackler School of Medicine, Herceg Institute of Aging, Tel Aviv University, Tel Aviv, Israel., Gerstein HC; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada., Basile J; Medical University of South Carolina, Ralph H. Johnson VA Medical Center, Charleston, SC, USA., Bethel MA; Eli Lilly and Company, Indianapolis, IN, USA., Cardona-Muñoz EG; CUCS-Universidad de Guadalajara, Mexico., Conget I; Endocrinology and Nutrition Dpt. Hospital Clinic i Universitari, Barcelona, Spain., Dagenais G; Quebec Heart and Lung Institute, Laval University, Quebec City, Canada., Franek E; Mossakowski Medical Research Centre, Polish Academy of Sciences and Central Clinical Hospital MSWiA, Warsaw, Poland., Hall S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada., Hancu N; Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania., Jansky P; University Hospital Motol, Prague., Lakshmanan M; Eli Lilly and Company, Indianapolis, IN, USA., Lanas F; Universidad de La Frontera, Temuco, Chile., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Canada., Lopez-Jaramillo P; Masira Research Institute, Medical School, Universidad de Santander UDES, Bucaramanga, Colombia., Pirags V; University of Latvia, Pauls Stradiņš Clinical University Hospital, Riga, Latvia., Pogosova N; National Medical Research Center of Cardiology, Moscow, Russia., Probstfield J; Department of Medicine, University of Washington, Seattle, WA,USA., Rao-Melacini P; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada., Ramasundarahettige C; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada., Raubenheimer PJ; Department of Medicine, University of Cape Town, Cape Town, South Africa., Riddle MC; Department of Medicine, Oregon Health & Science University Portland, OR, USA., Rydén L; Department of Medicine K2, Karolinska Institutet, Stockholm, Sweden., Shaw JE; Baker Heart and Diabetes Institute, Melbourne, Australia., Sheu WH; Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan., Temelkova-Kurktschiev T; Robert Koch Medical Center, Sofia, Bulgaria.
Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2022 Jul 14; Vol. 107 (8), pp. e3448-e3454.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1945-7197
DOI:10.1210/clinem/dgac200